Clinical trial reportClinical cancer research : an official journal of the American Association for Cancer ResearchPublished
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer
Regional connection
Verified Author affiliations on the Europe PMC record name Doylestown Hospital, Temple University Hospital, Thomas Jefferson University, with Penn Medicine, Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Ovarian Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Prospective Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; CTLA-4 Antigen; Programmed Cell Death 1 Receptor; Ipilimumab
- PubMed ID
- 39417692
- PubMed Central ID
- PMC11737520
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked